Great to see a growing community advancing evidence-informed health policy across the region. 👏
09.03.2026 09:08
👍 0
🔁 0
💬 0
📌 0
Great to see a growing community advancing evidence-informed health policy across the region. 👏
The workshop equipped researchers with practical skills to conduct model-based #economicevaluations using #Markovmodels in Excel, combining theory with hands-on model building and analysis. 📊
🎬 Watch the workshop highlights: youtu.be/06wOXvNlDiQ
Congratulations to all participants and partners who made this workshop a success! 🎉
#HealthEconomics #HealthTechnologyAssessment
#MarkovModel #EvidenceInformedPolicy #CapacityBuilding
🎉Celabrating the successful 4th Regional Workshop on Advanced #HealthEconomicEvaluation at JIPMER, Puducherry 🤝
🗝️ Participants gained hands-on skills in building #Markovmodels in Excel, conducting deterministic & probabilistic analyses, interpreting results, & reporting for peer-reviewed journals.
📍The reference case, methodology review, and systematic review/meta-analysis papers are all available at the link below:
🔗https://bit.ly/4s51t8I
🔗https://bit.ly/4rPSBEp
🔗https://bit.ly/3ZQvbSW
#HTA #EarlyHTA #PrecisionMedicine #HealthEconomics #LMICs #CostEffectiveness #EconomicEvaluation
How do we evaluate Precision Medicine from early R&D stage to market access, transparently and consistently❓
#PICCOTEAM offers
• 46 recommendations for conventional #EE
• 30 for early health technology assessment
💻 Tool to guide your analysis & generate structured reports:
piccoteam.gear4health.com
📃It was designed to expand choice but exposing ethical tensions and the delicate balance between access, quality, and integrity in UHC.
🔓 Full paper is ready now : rdcu.be/e4qK9
🚨 Access without safety isn’t progress—it’s systemic failure.
When access outpaces oversight, reforms can backfire. A new paper by Yot Teerawattananon (HITAP & SSHSPH of NUS) examines Thailand’s 2022 dialysis reform.
🔓 Read rdcu.be/e4qK9
🌍 Free for LICs via Research4Life: lnkd.in/g-GPuJN6
Key findings:
📊 C-section rates rose from 30% to 35% over five years
📊 Both clinical and non-clinical factors (age, region, hospital type, day of delivery) influenced use
📊 COVID-19 had no significant impact
#HITAP #HealthPolicy #UniversalCoverage #MaternalHealth #CaesareanSection #CSection
📢 New Publication Alert!
Are caesarean section rates in Thailand rising beyond what is medically necessary? 👶🏻
A new study by HITAP analyses national hospitalization data under Thailand’s Universal Coverage Scheme (2016–2021), covering over 500,000 C-section cases.
📃 bmjopen.bmj.com/content/16/2...
🔹Based on Thailand’s 2022 dialysis reform, the Commission examined system challenges, policy goals, and modeled policy options to assess impacts on dialysis systems in low- and middle-income countries.📃
🎥 Highlights now live: Nature Medicine Commission Report Launch on Dialysis Policy
▶️ youtu.be/ssncPDQDXtc
📄 Full report: www.nature.com/collections/...
#PMAC2026 #ChronicKidneyDisease #DialysisPolicy #ThailandUHC #LMICs
🗝️ The study shows significant gaps in animal and environmental data and calls for more representative evidence to guide policy.
📢 New Publication Alert:
🎉HITAP is excited to highlight a new open-access systematic review on data sources used in socioeconomic impact assessments of antimicrobial resistance from an One Health lens.
🔗Full article: bit.ly/4rUH7Pz
#OneHealth #AMR #HealthEconomics #HITAP
#PMAC2026 side meeting: #AMR in an ageing world— where rising infection risks demand policies that are both effective & equitable. We also proudly launched #GAPi in #Thailand to strengthen #antibioticpolicy through a health economics approach.
🎥Highlights: bit.ly/4bQZhwH
📃GAPi: bit.ly/3MkAwPc
⁉️What do you fund when resources are limited? Whose values count? What happens after a decision is made?
🗝️HTA is both a method and a process for priority setting
🗝️Policymakers seek evidence-informed, not purely evidence-based, decisions
🗝️Policy decisions are not linear and do not happen in isolation
What really happens when evidence meets policy?
🤝HITAP hosted the Duke–NUS #EMHEAL for a focused session on Health Technology Assessment. Together with healthcare leaders from across sectors, the conversation moved beyond frameworks to the realities of decision-making.
A new short course on “Vaccinology: Science and Public Health” is coming to Nagasaki, Japan. This course is designed for vaccine researchers and public health professionals involved in/or interested in vaccine research, development, epidemiology, policy, and implementation. Dates: 24–28 August 2026. Learn more & apply: https://www.tmgh.nagasaki-u.ac.jp/en/short-courses/vaccinology-science-and-public-health.
📢 Now Open for Applications!
A new short course on “Vaccinology: Science and Public Health” is coming to Nagasaki, Japan.
📅 Dates: 24–28 August 2026
🎓 Certificate of Participation awarded upon completion
🔗 Learn more & apply: www.tmgh.nagasaki-u.ac.jp/en/short-cou...
✴️ Huge thanks to our co-hosts for making this a meaningful discussion: World Bank Group (WBG), Health Intervention and Technology Assessment Program Foundation (HITAP), Asian Development Bank, National University of Singapore, Japan International Cooperation Agency (JICA), and Mahidol University.
💡 These discussions contribute to ongoing policy conversations on how health systems can evolve to respond to demographic transition—while remaining equitable, sustainable, and people-centered.
#PMAC2026 #PMAC #DemographicShifts #HealthSystem #GlobalHealth
Plus, reflections from both speakers and participants, captured through plenary discussions and audience engagement, consistently highlighted equity as a key consideration in responding to demographic transition.
⏩ Leveraging digital health and AI to support overstretched workforces, built on a robust digital backbone
⏩ Designing partnerships that respect regional and local priorities, and amplify local voices
⏩ Reframing health not as a cost, but as an investment in human dignity and economic growth
⏩ Strengthening prevention and health promotion
⏩ Investing in people, primary health care, and compassionate, patient-centered services
Speakers identified key pathways forward, including insights from Dr. Feng Zhao (World Bank), Dasho Dechen Wangmo (PEMA Secretariat), Prof. Ntobeko Ntusi (South African Medical Research Council), Dr. Jimmy Volmink (Wellcome Trust), and Dr. Li Ailan (WHO Thailand) on:
(cont)
At #PMAC2026, Plenary 2 “Demographic Shifts and Health System Transformation” examined two key questions:
🗨️ Are health systems ready for shifting demographics and what happens if we fail to act now?
🗨️ How can health systems respond to shifting demographics without leaving equity behind?
As countries face demographic changes such as population ageing, health systems are being tested not only by rising NCDs, increasing health expenditure, workforce shortages, and fragile health financing, but also by the growing concern about equity.
Thank you to all our speakers for their valuable contributions to shaping a more sustainable health system. 🍀
See how evidence can shape better dialysis policy: www.nature.com/collections/...
👤 Ben Johnson framed the Commission as a global model for UHC, observing that every nation operates in a resource-limited setting and must protect patient choice from being a commercial illusion.
Evidence matters, but how we act on it matters even more.
Karen O’Leary highlighted that while Thailand is the case study, the Commission offers global lessons on how evidence-based policymaking and collaboration can help address the growing commodification of essential healthcare. Ben Johnson framed the Commission as a global model for UHC, observing that every nation operates in a resource-limited setting and must protect patient choice from being a commercial illusion. Evidence matters, but how we act on it matters even more.
👤 Karen O’Leary highlighted that while Thailand is the case study, the Commission offers global lessons on how evidence-based policymaking and collaboration can help address the growing commodification of essential healthcare.
Dr. Kriang Tungsanga addressed the conflict of interest when medical care enters the stock market, noting that the drive for profit can shift the core medical mindset away from patient-centered virtue.
👤 Dr. Kriang Tungsanga addressed the conflict of interest when medical care enters the stock market, noting that the drive for profit can shift the core medical mindset away from patient-centered virtue.